CorMedix (CRMD) Inventory Average (2016 - 2026)
CorMedix (CRMD) posted Inventory Average of $29.3 million for Q4 2025, up 85.84% sequentially from $15.8 million in Q3 2025, and up 662.6% YoY from $3.8 million in Q4 2024.
CorMedix (CRMD) Inventory Average (2016 - 2026) Analysis & Trends
CorMedix has reported Inventory Average for 9 years, with the latest figure at $29.3 million in Q4 2025.
- Quarterly Inventory Average rose 662.6% year-over-year to $29.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.3 million (up 662.6% YoY) and the FY2025 annual result came in at $15.4 million, up 877.79% from the prior year.
- Inventory Average advanced to $29.3 million in Q4 2025 per CRMD's latest filing, from $15.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $29.3 million in Q4 2025 and troughed at $994.5 in Q3 2022.
- A 4-year average of $4.4 million and a median of $1.7 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average sank 98.36% in 2022, then jumped 662.6% in 2025.
- Over 4 years, Inventory Average stood at $25963.0 in 2021, then tumbled by 96.17% to $994.5 in 2022, then jumped by 386450.78% to $3.8 million in 2024, then surged by 662.6% to $29.3 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $29.3 million, $15.8 million, and $5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 34.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.15 Mn |
| Dec 31, 2025 | 29.32 Mn |
| Sep 30, 2025 | 15.78 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Sep 30, 2022 | 994.50 |
| Jun 30, 2022 | 2,167.00 |
| Mar 31, 2022 | 2,811.00 |
| Dec 31, 2021 | 25,963.00 |
| Sep 30, 2021 | 60,822.50 |
| Jun 30, 2021 | 78,899.00 |
| Mar 31, 2021 | 114,317.50 |
| Dec 31, 2020 | 172,135.00 |
| Sep 30, 2020 | 239,270.50 |
| Jun 30, 2020 | 286,371.50 |
| Mar 31, 2020 | 316,686.50 |